Propanc Biopharma, Inc.
PPCB · XNASCIK 1517681fmd_0MH729REF209ES2866FTX2VH70Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jul 02, 2007 to Jun 30, 2026, 67 periods
Latest annual · FY2026
Millions- Operating income
- (18)
- Net income
- (19)
- Free cash flow
- (6)
Latest quarter · Q4 FY2026
Millions- Operating income
- (3)
- Net income
- (5)
- Free cash flow
- (2)
Daily close · PPCBIEX trades only
Sep 02, 2025 to Nov 10, 2026 · 250 sessions1.74 USD
Built from trades executed at IEX only, one exchange with a small share of US volume. This is not the consolidated tape. The close is the last IEX trade of the session, not the official closing price. Earlier sessions are divided by the later split ratios the API confirmed against IEX prices; dividends are not adjusted. Switch to As traded for the prices as they printed. End of day, not real time: a session is published the day after it trades.
Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use. iex.io/legal/hist-data-terms
Key stats
Open AnalysisCompound annual growth
- Net income, 5 yearsFY2021 to FY2026
- n/m
Propanc Biopharma, Inc. (PPCB) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2026 | FY2025 | Change | Source |
|---|---|---|---|---|
| Operating income | -$18.2 million | -$57.3 million | 10-K 2026-09-25 · proof | |
| Net income | -$18.9 million | -$58.9 million | 10-K 2026-09-25 · proof | |
| Cash from operating activities | -$5.7 million | -$405,168 | 10-K 2026-09-25 · proof | |
| Free cash flow | -$5.7 million | 10-K 2026-09-25 · proof | ||
| Total assets | $12.8 million | $19.6 million | -34.9% | 10-K 2026-09-25 · proof |
| Total liabilities | $3.4 million | $5.7 million | -41% | 10-K 2026-09-25 · proof |
| Cash and cash equivalents | $832,006 | $12,088 | +6,782.9% | 10-K 2026-09-25 · proof |
- What was Propanc Biopharma, Inc. (PPCB)'s operating income in fiscal 2026?
- Propanc Biopharma, Inc. (PPCB) reported operating income of -$18.2 million for fiscal 2026 (the year ended Jun 30, 2026), against -$57.3 million the year before. Source: the 10-K filed with the SEC on Sep 25, 2026. SEC
- What was Propanc Biopharma, Inc. (PPCB)'s net income in fiscal 2026?
- Propanc Biopharma, Inc. (PPCB) reported net income of -$18.9 million for fiscal 2026 (the year ended Jun 30, 2026), against -$58.9 million the year before. Source: the 10-K filed with the SEC on Sep 25, 2026. SEC
- What was Propanc Biopharma, Inc. (PPCB)'s cash from operating activities in fiscal 2026?
- Propanc Biopharma, Inc. (PPCB) reported cash from operating activities of -$5.7 million for fiscal 2026 (the year ended Jun 30, 2026), against -$405,168 the year before. Source: the 10-K filed with the SEC on Sep 25, 2026. SEC
- What was Propanc Biopharma, Inc. (PPCB)'s free cash flow in fiscal 2026?
- Propanc Biopharma, Inc. (PPCB) reported free cash flow of -$5.7 million for fiscal 2026 (the year ended Jun 30, 2026). Source: the 10-K filed with the SEC on Sep 25, 2026. SEC
- What are Propanc Biopharma, Inc. (PPCB)'s total assets?
- As of Jun 30, 2026, Propanc Biopharma, Inc. (PPCB) reported total assets of $12.8 million, against $19.6 million a year earlier (-34.9%). Source: the 10-K filed with the SEC on Sep 25, 2026. SEC
- What are Propanc Biopharma, Inc. (PPCB)'s total liabilities?
- As of Jun 30, 2026, Propanc Biopharma, Inc. (PPCB) reported total liabilities of $3.4 million, against $5.7 million a year earlier (-41%). Source: the 10-K filed with the SEC on Sep 25, 2026. SEC
- What are Propanc Biopharma, Inc. (PPCB)'s cash and cash equivalents?
- As of Jun 30, 2026, Propanc Biopharma, Inc. (PPCB) reported cash and cash equivalents of $832,006, against $12,088 a year earlier (+6,782.9%). Source: the 10-K filed with the SEC on Sep 25, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:PPCB&period_type=annual&limit=5"Information only, not investment advice.